🇺🇸 FDA
Patent

US 6994858

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

expired A61KA61K35/28A61K35/765

Quick answer

US patent 6994858 (Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions) held by ONCOLYTICS BIOTECH INC. expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K35/28, A61K35/765, A61K48/00, A61P